Literature DB >> 17476567

Atrial natriuretic peptide increases urinary albumin excretion in people with normoalbuminuric type-2 diabetes.

K B Moore1, K McKenna, M Osman, W P Tormey, D McDonald, C J Thompson.   

Abstract

BACKGROUND: Atrial natriuretic peptide (ANP) is elevated in patients with type-2 diabetes and microalbuminuria. The purpose of this study is to evaluate if ANP increases Urinary Albumin Eaxcretion Rate (UAER) in type-2 diabetes.
METHODS: Eight normoalbuminuric diabetic subjects underwent a randomised single blind study of 60 min intravenous infusion of ANP or vehicle. Eight non-diabetic controls underwent ANP infusion alone. Seven normoalbuminuric type-2 diabetes subjects received further ANP infusions during euglycaemia and during hyperglycaemia.
RESULTS: ANP increased urinary sodium (191.3 +/- 80.7 to 529.2 +/- 263.4 mumol/min, mean +/- SD, and P < 0.001) and UAER (72.2 +/- 73.4 to 224.9 +/- 182.9.5 mug/min, and P < 0.01) in diabetic subjects. In controls, UAER did not change significantly (P = 0.16); however, the natriuretic response to ANP was similar to diabetic subjects (P = 0.98). Hyperglycaemic did not enhance the albuminuric response to ANP (P = 0.88).
CONCLUSION: ANP increases UAER in normoalbuminuric type-2 diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17476567     DOI: 10.1007/s11845-007-0030-1

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  30 in total

1.  Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.

Authors:  T J Allen; Z Cao; S Youssef; U L Hulthen; M E Cooper
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

2.  Atrial natriuretic peptide in type 2 diabetes mellitus: response to a physiological mixed meal and relationship to renal function.

Authors:  P D Chattington; J V Anderson; L H Rees; G P Leese; J R Peters; J P Vora
Journal:  Diabet Med       Date:  1998-05       Impact factor: 4.359

3.  Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in Type 1 diabetes mellitus.

Authors:  K McKenna; D Smith; W Tormey; C J Thompson
Journal:  Diabet Med       Date:  2000-07       Impact factor: 4.359

4.  Effect of alpha-human atrial natriuretic peptide on proteinuria in patients with primary glomerular diseases.

Authors:  M Ishi; Y Hirata; T Sugimoto; H Matsuoka; K Kimura; T Ishimitsu; K Fukui; T Sugimoto; Y Kurosawa; H Kiyose
Journal:  Clin Sci (Lond)       Date:  1989-12       Impact factor: 6.124

5.  Relationship between early metabolic control and the development of microalbuminuria--a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Rudberg; E Ullman; G Dahlquist
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

6.  Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats.

Authors:  N Perico; A Benigni; M Gabanelli; A Piccinelli; M Ròg; C De Riva; G Remuzzi
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

7.  Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus.

Authors:  G M Bell; R K Bernstein; J H Laragh; S A Atlas; G D James; M S Pecker; J E Sealey
Journal:  Clin Sci (Lond)       Date:  1989-08       Impact factor: 6.124

8.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

9.  The effect of atrial natriuretic factor on urinary albumin and beta 2-microglobulin excretion in man.

Authors:  J McMurray; P H Seidelin; J E Howey; D J Balfour; A D Struthers
Journal:  J Hypertens       Date:  1988-10       Impact factor: 4.844

10.  Enhanced urinary excretion of albumin and beta 2 microglobulin in essential hypertension induced by atrial natriuretic peptide.

Authors:  H Eiskjaer; C E Mogensen; A Schmitz; E B Pedersen
Journal:  Scand J Clin Lab Invest       Date:  1991-06       Impact factor: 1.713

View more
  3 in total

Review 1.  Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease.

Authors:  Yang Yang; Gaosi Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

Review 2.  Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide.

Authors:  Estera Rintz; Grzegorz Węgrzyn; Toshihito Fujii; Shunji Tomatsu
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

3.  The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial.

Authors:  Motoko Kanzaki; Jun Wada; Yoko Kikumoto; Shigeru Akagi; Kazushi Nakao; Hitoshi Sugiyama; Hirofumi Makino
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.